Chemours met revenue expectations but missed profit expectations in the fourth quarter. The stock had roughly doubled since late November, so a pullback on anything less than perfect is no surprise.
| Quartal / Datum | EPS (USD) | Schätzung (USD) | Abweichung |
|---|
| Quartal / Datum | Umsatz (Mio USD) | Schätzung (Mio USD) | Abweichung |
|---|